Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern
暂无分享,去创建一个
J. Diallo | J. van Grevenynghe | J. Hiscott | S. Paludan | J. Bell | M. Côté | R. Singaravelu | R. Arulanandam | L. Sabourin | M. Jakobsen | C. Holm | A. L. Hansen | M. Idorn | D. Di Carlo | T. Azad | Glib Maznyi | Zaid Taha | G. Laroche | Léna Cassin | K. Fu | M. Carter-Timofte | N. Kurmasheva | Tommy Alain | D. Olagnier | D. van der Horst | Enrico Palermo | J. Seguin | Renée M. Van der Sluis | David Jacobs | Fanghui Ren | Naziia Kurmasheva | Madalina E. Carter-Timofte